Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease

7Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Studies of Alzheimer’s disease (AD) using experimental systems most often involve transgenic mouse models that are characterized by neural accumulation of β-amyloid protein (Aβ), which is widely hypothesized to have a key role in AD pathogenesis. Quantification of Aβ in transgenic mice typically is accomplished through both biochemical and histochemical approaches. In this chapter, we describe two techniques for the histological detection of Aβ, immunostaining with Aβ antibodies and staining with the amyloid dye thioflavin S, and its quantification using digital imaging.

Cite

CITATION STYLE

APA

Christensen, A., & Pike, C. J. (2020). Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer’s Disease. In Methods in Molecular Biology (Vol. 2144, pp. 211–221). Humana Press Inc. https://doi.org/10.1007/978-1-0716-0592-9_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free